The effect of sevelamer on tacrolimus target levels

Transplantation

Volumn 80, Issue 5, 2005, Pages 707-

  Merkle, Monika ^a,b   Wornle, Markus ^a   Rupprecht, Harald D ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Kidney transplantation; Sevelamer; Tacrolimus

Indexed keywords

IMMUNOGLOBULIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SEVELAMER; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG TARGETING; GRAFT SURVIVAL; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; REOPERATION;

DRUG INTERACTIONS; GLOMERULONEPHRITIS, IGA; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYAMINES; RECURRENCE; TACROLIMUS;

EID: 25444490388     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000172220.41719.31     Document Type: Article

References (3)

1. Pieper AK, Buhle F, Bauer S, et al. The effect of sevelamer on the pharmacokinetics of cyclosporin A and mycophenolate mofetil after renal transplantation. Nephrol Dial Transplant 2004; 19: 2630.
2. Guillen-Anaya MA, Jadoul M. Drug interaction between sevelamer and cyclosporin. Nephrol Dial Transplant 2004; 19: 515.
3. Wauters JP, Uehlinger D, Marti HP. Drug interaction between sevelamer and cyclosporin. Nephrol Dial Transplant 2004; 19: 1939.